With 74% Institutional Ownership, Codexis, Inc. (NASDAQ:CDXS) Is a Favorite Amongst the Big Guns
Yahoo FinanceApr 26 09:08 ET
Codexis (CDXS) Gets a Buy From Piper Sandler
TipRanksApr 26 07:50 ET
Codexis to Report First Quarter 2024 Financial Results on May 2
REDWOOD CITY, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the first quarter of 2024 on
GlobeNewswireApr 18 16:05 ET
Express News | Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board
Moomoo 24/7Apr 11 07:05 ET
Favourable Signals For Codexis: Numerous Insiders Acquired Stock
Yahoo FinanceMar 30 08:57 ET
AQST,CDXS and STI Are Among After Hour Movers
Seeking AlphaMar 19 17:37 ET
Benchmark Raises Codexis to Buy; Cites Q4 Earnings, Guidance
Seeking AlphaMar 1 15:37 ET
Piper Sandler Sticks to Their Buy Rating for Codexis (CDXS)
TipRanksMar 1 07:48 ET
A New Cause for Concern: Codexis Adds a New Corporate Activity and Growth Risk
TipRanksMar 1 01:00 ET
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersCardiff Oncology (NASDAQ:CRDF) shares moved upwards by 28.6% to $2.27 during Thursday's after-market session. The company's market cap stands at $101.4 million. As per the press release, Q4 ear
BenzingaFeb 29 16:31 ET
Codexis Raised to Buy From Hold by Benchmark
Codexis Raised to Buy From Hold by Benchmark
Dow JonesFeb 29 10:50 ET
Express News | Benchmark Upgrades Codexis to Buy, Announces $9 Price Target
Moomoo 24/7Feb 29 10:41 ET
Codexis Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 02/29/2024 141.94% Benchmark → $9 Upgrades Hold → Buy 11/07/2023 — Benchmark Downgrades Buy → Hold 11/06/
BenzingaFeb 29 10:39 ET
Ampio Pharmaceuticals, Ironwood, Incannex Among Healthcare Movers
Seeking AlphaFeb 29 10:00 ET
Stifel Nicolaus Keeps Their Buy Rating on Codexis (CDXS)
TipRanksFeb 29 08:19 ET
Earnings Call Summary | Codexis(CDXS.US) Q4 2023 Earnings Conference
The following is a summary of the Codexis, Inc. (CDXS) Q4 2023 Earnings Call Transcript:Financial Performance:Codexis reported Q4 2023 total revenues of $18.4 million, up from $13 million in Q4 2022.P
moomoo AIFeb 29 08:16 ET · Conference Call
Analysts Have Conflicting Sentiments on These Healthcare Companies: Butterfly Network (BFLY) and Codexis (CDXS)
TipRanksFeb 28 22:20 ET
Express News | Codexis Sees FY24 Product Revenue $38M-$42M, Excluding Revenue Related To PAXLOVID; R&D Revenue $18M-$22M
Moomoo 24/7Feb 28 16:49 ET
Recap: Codexis Q4 Earnings
Codexis (NASDAQ:CDXS) reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsCodexis beat estimated earnings by
BenzingaFeb 28 16:35 ET
Codexis GAAP EPS of -$0.10 Beats by $0.04, Revenue of $26.56M Beats by $7.63M
Seeking AlphaFeb 28 16:14 ET
No Data
No Data